US2018094297A1PendingUtilityA1
Gene expression profiling from ffpe samples
Est. expiryOct 11, 2022(expired)· nominal 20-yr term from priority
C12Q 2527/125C12Q 1/6837C12Q 1/6806C12N 15/1096C12Q 2600/158C12Q 1/6809G06F 19/20C12Q 1/6886G16B 25/10G16B 25/00
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and compositions relating to the generation and use of gene expression data from tissue samples that have been fixed and embedded are provided. The data can electronically stored and implemented as well as used to augment diagnosis and treatment of diseases.
Claims
exact text as granted — not AI-modified1 . A method of synthesizing cDNA from the polyadenylated RNA from cells of an FFPE sample comprising
a) extracting said RNA from said cells; and b) contacting said extracted RNA with a primer comprising an oligo dT sequence under conditions that result in the synthesis of a first cDNA strand complementary to said extracted RNA.
2 . The method of claim 1 further comprising heating said RNA extracted from said cells at about 70° C. before contacting said RNA with said primer.
3 . The method of claim 1 wherein said extracting of RNA from said cells comprises
obtaining said cells from said sample;
digesting said cells with proteinase K to produce digested material;
contacting the digested material with a guanidinium containing compound to produce a mixture;
contacting the mixture with a silica matrix to permit RNA binding to the matrix; and
eluting the bound RNA after removal of unbound matter.
4 . The method of claim 2 wherein said heating is for about 3 to about 8 hours.
5 . The method of claim 4 wherein said heating is for about 3 hours.
6 . The method of claim 1 further comprising synthesis of the second cDNA strand by use of random primers.
7 . The method of claim 1 further comprising synthesis of the second cDNA strand in the absence of random primers.
8 . The method of claim 1 wherein said primer is operably linked to a promoter sequence.
9 . The method of claim 6 wherein said random primers are hexamers, heptamers, octamers, or nonamers.
10 . The method of claim 2 wherein said extracting of RNA from said cells comprises
obtaining said cells from said sample;
digesting said cells with proteinase K to produce digested material;
contacting the digested material with a guanidinium containing compound to produce a mixture;
contacting the mixture with a silica matrix to permit RNA binding to the matrix; and
eluting the bound RNA after removal of unbound matter.
11 . The method of claim 10 wherein said heating is for about 3 to about 8 hours.
12 . The method of claim 11 wherein said heating is for about 3 hours.
13 - 14 . (canceled)
15 .A computer readable medium containing a gene expression profile represented as a data structure, said medium having a plurality of data fields stored on the medium and comprising
a first data field representing gene expression profile data that is to be analyzed, said first data field being stored in a range of addresses in said computer readable medium; one or more receiver objects that will receive test sample expression data for analysis with said gene expression profile data, each receiver object being stored in a separate range of addresses in said computer readable medium, wherein each receiver object comprises a data field adapted for storing input information for correlation or analysis with said first data field.
16 . The medium of claim 15 wherein said first data field is stored in a range of addresses used by one of said one or more receiver objects.
17 . The medium of claim 15 further comprising a prompt field adapted for storing one or more data prompts to elicit entry of test sample expression data.
18 . The medium of claim 15 wherein said test sample expression data is obtained from cells of a tissue containing sample from a human patient.
19 . The medium of claim 15 wherein said gene expression profile data is derived from amplification of polyadenylated mRNA from one or more FFPE samples.
20 . A system for correlating gene expression data from an FFPE sample with a disease or treatment outcome experienced by the subject from which said sample was obtained comprising
means for generating said gene expression data by amplification of polyadenylated mRNA from said FFPE sample; and means for identifying one or more gene expression levels correlated with at least one disease or treatment outcome experienced by said subject.Join the waitlist — get patent alerts
Track US2018094297A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.